These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14578861)

  • 1. Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function.
    Park GJ; Katelaris PH; Jones DB; Seow F; Le Couteur DG; Ngu MC
    Hepatology; 2003 Nov; 38(5):1227-36. PubMed ID: 14578861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test.
    Park GJ; Wiseman E; George J; Katelaris PH; Seow F; Fung C; Ngu MC
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1411-6. PubMed ID: 21557768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the 13C-methacetin breath test for quantitative liver function testing.
    Klatt S; Taut C; Mayer D; Adler G; Beckh K
    Z Gastroenterol; 1997 Aug; 35(8):609-14. PubMed ID: 9297776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection.
    Braden B; Faust D; Sarrazin U; Zeuzem S; Dietrich CF; Caspary WF; Sarrazin C
    Aliment Pharmacol Ther; 2005 Jan; 21(2):179-85. PubMed ID: 15679768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy.
    Park GJ; Katelaris PH; Jones DB; Seow F; Lin BP; Le Couteur DG; Ngu MC
    Aliment Pharmacol Ther; 2005 Sep; 22(5):395-403. PubMed ID: 16128677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 13C-caffeine breath test detects significant fibrosis in patients with nonalcoholic steatohepatitis.
    Schmilovitz-Weiss H; Niv Y; Pappo O; Halpern M; Sulkes J; Braun M; Barak N; Rotman Y; Cohen M; Waked A; Tur-Kaspa R; Ben-Ari Z
    J Clin Gastroenterol; 2008 Apr; 42(4):408-12. PubMed ID: 18277896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
    Joeres R; Brachtel D; Gallenkamp H; Hofstetter G; Klinker H; Zilly W; Richter E
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine clearance by two point analysis: a measure of liver function in chronic liver disease.
    Wittayalertpanya S; Israsena S; Thamaree S; Tongnopnoua P; Komolmit P
    Tokai J Exp Clin Med; 1996 Dec; 21(4-6):195-201. PubMed ID: 9300980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of liver disease on urine caffeine metabolite ratios.
    Denaro CP; Wilson M; Jacob P; Benowitz NL
    Clin Pharmacol Ther; 1996 Jun; 59(6):624-35. PubMed ID: 8681487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The caffeine breath test does not identify patients susceptible to tacrine hepatotoxicity.
    Fontana RJ; Turgeon DK; Woolf TF; Knapp MJ; Foster NL; Watkins PB
    Hepatology; 1996 Jun; 23(6):1429-35. PubMed ID: 8675160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 13C-methacetin breath test: isotope-selective nondispersive infrared spectrometry in comparison to isotope ratio mass spectrometry in volunteers and patients with liver cirrhosis.
    Adamek RJ; Goetze O; Boedeker C; Pfaffenbach B; Luypaerts A; Geypens B
    Z Gastroenterol; 1999 Dec; 37(12):1139-43. PubMed ID: 10666836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.
    Mion F; Queneau PE; Rousseau M; Brazier JL; Paliard P; Minaire Y
    Hepatogastroenterology; 1995; 42(6):931-8. PubMed ID: 8847048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The 13C-methacetin breath test for quantitative noninvasive liver function analysis with an isotope-specific nondispersive infrared spectrometer in liver cirrhosis].
    Pfaffenbach B; Götze O; Szymanski C; Hagemann D; Adamek RJ
    Dtsch Med Wochenschr; 1998 Dec; 123(49):1467-71. PubMed ID: 9861887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis.
    Spahr L; Negro F; Leandro G; Marinescu O; Goodman KJ; Rubbia-Brandt L; Jordan M; Hadengue A
    Med Sci Monit; 2003 Jan; 9(1):CR6-11. PubMed ID: 12552242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum metabolite/caffeine ratios as a test for liver function.
    Jodynis-Liebert J; Flieger J; Matuszewska A; Juszczyk J
    J Clin Pharmacol; 2004 Apr; 44(4):338-47. PubMed ID: 15051740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 13C-methacetin breath test shortened: 2-point-measurements after 15 minutes reliably indicate the presence of liver cirrhosis.
    Schneider A; Caspary WF; Saich R; Dietrich CF; Sarrazin C; Kuker W; Braden B
    J Clin Gastroenterol; 2007 Jan; 41(1):33-7. PubMed ID: 17198062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 13C-methacetin and 13C-galactose breath tests can assess restricted liver function even in early stages of primary biliary cirrhosis.
    Holtmeier J; Leuschner M; Schneider A; Leuschner U; Caspary WF; Braden B
    Scand J Gastroenterol; 2006 Nov; 41(11):1336-41. PubMed ID: 17060128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of the study of caffeine elimination in chronic liver diseases].
    Darnót G; Nemesánszky E; Bariska J
    Orv Hetil; 1995 Apr; 136(18):927-32. PubMed ID: 7739851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.